Inspire Medical Systems, Inc.
INSP
$81.79
-$2.02-2.41%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.81% | 22.05% | 27.11% | 28.49% | 32.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.81% | 22.05% | 27.11% | 28.49% | 32.52% |
| Cost of Revenue | 15.72% | 24.97% | 27.10% | 27.35% | 26.89% |
| Gross Profit | 17.01% | 21.53% | 27.12% | 28.70% | 33.58% |
| SG&A Expenses | 17.96% | 16.29% | 15.28% | 17.18% | 21.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.99% | 13.88% | 13.40% | 15.28% | 19.68% |
| Operating Income | 172.13% | 389.66% | 238.41% | 189.60% | 127.04% |
| Income Before Tax | 40.36% | 589.12% | 612.11% | 393.65% | 216.27% |
| Income Tax Expenses | 86.03% | 124.92% | 224.87% | 296.47% | 347.93% |
| Earnings from Continuing Operations | 34.82% | 783.73% | 522.69% | 352.96% | 200.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.82% | 783.73% | 522.69% | 352.96% | 200.86% |
| EBIT | 172.13% | 389.66% | 238.41% | 189.60% | 127.04% |
| EBITDA | 168.37% | 598.11% | 278.03% | 213.92% | 138.86% |
| EPS Basic | 34.90% | 785.52% | 514.98% | 345.49% | 199.09% |
| Normalized Basic EPS | 62.67% | 636.41% | 602.47% | 384.87% | 214.23% |
| EPS Diluted | 36.16% | 852.96% | 493.41% | 332.77% | 195.08% |
| Normalized Diluted EPS | 63.97% | 671.93% | 576.78% | 371.00% | 210.34% |
| Average Basic Shares Outstanding | -0.31% | 0.58% | 1.20% | 1.58% | 1.82% |
| Average Diluted Shares Outstanding | -0.60% | 1.32% | 3.09% | 2.96% | 2.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |